Cumberland Pharmaceuticals Inc (CPIX)
1.525
+0.08
(+5.17%)
USD |
NASDAQ |
May 31, 16:00
1.48
-0.04
(-2.95%)
Pre-Market: 20:00
Cumberland Pharmaceuticals Profit Margin (Quarterly): -22.90% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -22.90% |
December 31, 2023 | -67.30% |
September 30, 2023 | -10.40% |
June 30, 2023 | 8.01% |
March 31, 2023 | 2.08% |
December 31, 2022 | -26.75% |
September 30, 2022 | -3.58% |
June 30, 2022 | -12.97% |
March 31, 2022 | -12.40% |
December 31, 2021 | -46.25% |
September 30, 2021 | -13.07% |
June 30, 2021 | 13.57% |
March 31, 2021 | 1.58% |
December 31, 2020 | -8.61% |
September 30, 2020 | -5.21% |
June 30, 2020 | -9.57% |
March 31, 2020 | -12.67% |
December 31, 2019 | -10.32% |
September 30, 2019 | -28.17% |
June 30, 2019 | -5.84% |
March 31, 2019 | -0.85% |
December 31, 2018 | -105.7% |
September 30, 2018 | -19.35% |
June 30, 2018 | -7.09% |
March 31, 2018 | -27.71% |
Date | Value |
---|---|
December 31, 2017 | -6.87% |
September 30, 2017 | -6.64% |
June 30, 2017 | -59.54% |
March 31, 2017 | -13.22% |
December 31, 2016 | -8.26% |
September 30, 2016 | 1.21% |
June 30, 2016 | -0.65% |
March 31, 2016 | -3.27% |
December 31, 2015 | 1.88% |
September 30, 2015 | 1.61% |
June 30, 2015 | 4.56% |
March 31, 2015 | 0.53% |
December 31, 2014 | 7.17% |
September 30, 2014 | 7.67% |
June 30, 2014 | 7.41% |
March 31, 2014 | 3.54% |
December 31, 2013 | -18.39% |
September 30, 2013 | -12.56% |
June 30, 2013 | -9.02% |
March 31, 2013 | 8.33% |
December 31, 2012 | 13.18% |
September 30, 2012 | 14.92% |
June 30, 2012 | 14.10% |
March 31, 2012 | 4.13% |
December 31, 2011 | 7.00% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-67.30%
Minimum
Dec 2023
13.57%
Maximum
Jun 2021
-13.54%
Average
-10.36%
Median
Profit Margin (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -122.2% |
Palatin Technologies Inc | -- |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -25.51% |
Return on Assets | -9.79% |
Return on Invested Capital | -17.83% |
Gross Profit Margin (Quarterly) | 81.46% |
Operating Margin (Quarterly) | -22.00% |
Return on Net Operating Assets | -15.85% |